| Products |
|
|
 |
| Contact Us |
 |
Address: 2766 Yingxiu Road, Jinan High-Tech Zone, China |
 |
Tel:
Sales: +86-531-88811783
Evaluation:+86-531-88806178
R&D: +86-531-88813691
Office: +86-531-88817621 |
 |
Fax: +86-531-88817925 |
 |
Zip Code: 250101 |
 |
Email:
Trade Department:
sales@trio-pharmatech.com
G&D&E:
register@trio-pharmatech.com
yzxpj@trio-pharmatech.com
R&D center::
newdrugs@trio-pharmatech.com |
|
|
|
|
| Product No. |
CAS No. |
Name |
Category |
| TP1008DZ06 |
N.A |
Imatinib Para-diaMinoMethylbenzene |
Imatinib Series
|
| TP1009A |
848942-61-0, 1196531-39-1 (diFumaric acid) |
AZD8931; Sapitinib |
Inhibitors of EGFR pathways
|
| TP1010A |
915019-65-7, 1028385-32-1 (4-methylbenzenesulfonate) |
BEZ235; NVP-BEZ235 |
Inhibitors of EGFR pathways
|
| TP1010A |
915019-65-7, 1028385-32-1 (4-methylbenzenesulfonate) |
BEZ235; NVP-BEZ235 |
Inhibitors of PI3K-Akt-mTOR pathways
|
| TP1011A |
714971-09-2, 873837-23-1 (HCl), 873837-22-0 (H2O) |
BMS-599626; AC480 |
Inhibitors of EGFR pathways
|
| TP1012A |
267243-28-7, 289499-45-2 (2HCl) |
CI-1033; Canertinib |
Inhibitors of EGFR pathways
|
| TP1013A |
537705-08-1 |
CP-724714 |
Inhibitors of EGFR pathways
|
| TP1014A |
1012054-59-9, 1012060-66-0 (L(+)-Tartaric Acid) |
CUDC-101 |
Inhibitors of EGFR pathways
|
| TP1015A |
1110813-31-4, 1042385-75-0 (H2O) |
Dacomitinib; PF299804,PF-00299804 |
Inhibitors of EGFR pathways
|
| TP1016A |
1020172-07-9 |
DCC-2036; Rebastinib |
Inhibitors of EGFR pathways
|
| TP1017A |
183321-74-6, 183319-69-9 (HCl) |
Erlotinib; NSC 718781; CP 358,774 |
Inhibitors of EGFR pathways
|
| TP1018A |
184475-35-2 |
Gefitinib; Iressa |
Inhibitors of EGFR pathways
|
| TP1019A |
610798-31-7 (free base) |
Icotinib; BPI-2009H |
Inhibitors of EGFR pathways
|
| TP1019DZ01 |
N/A |
Alogliptin Benzoate impurity A |
Alogliptin Benzoate impurity
|
| TP1019DZ02 |
N/A |
Alogliptin Benzoate impurity B |
Alogliptin Benzoate impurity
|
| TP1019DZ03 |
N/A |
Alogliptin Benzoate impurity C |
Alogliptin Benzoate impurity
|
| TP1019DZ04 |
N/A |
6-(6-chloro-3,4-dihydro-3-methyl-2,4-dioxopyrimidin-1(2H)-yl)-3-methylpyrimidine-2,4(1H,3H)-dione |
Alogliptin Benzoate impurity
|
| TP1019DZ05 |
N/A |
2-((6-((R)-3-aminopiperidin-1-yl)-3,4-dihydro-3-methyl-2,4-dioxopyrimidin-1(2H)-yl)methyl)benzamide |
Alogliptin Benzoate impurity
|
| TP1019DZ06 |
N/A |
2-((3,4-dihydro-6-isopropoxy-3-methyl-2,4-dioxopyrimidin-1(2H)-yl)methyl)benzonitrile |
Alogliptin Benzoate impurity
|
| TP1019DZ07 |
50721-47-6 |
6-chloro-3-ethylpyrimidine-2,4(1H,3H)-dione |
Alogliptin Benzoate impurity
|
|
|
|
